An Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
An Jin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Gang Li
School of Pharmaceutical Sciences Hunan University of Medicine Huaihua China
2 shared publications - Wenming Wu
Department of Pharmacy Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang China
2 shared publications - Hui Li
Department of Pharmacy Jiangxi Provincial People's Hospital The First Affiliated Hospital of Nanchang Medical College Nanchang China
1 shared publication Lingfei Tong
Department of Pharmacy Jiangxi Provincial People's Hospital The First Affiliated Hospital of Nanchang Medical College Nanchang China
1 shared publicationQinxue Luo
School of Pharmaceutical Sciences Hunan University of Medicine Huaihua China
1 shared publicationRuiyue Hu
Department of Pharmacy Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang China
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Phenolic Glycosides From Ficus erecta and Their Anti‐Inflammatory and Neuroprotective Activities
Five undescribed phenolic glycosides, ficuserectosides A‐E ( 1 – 5 ), and three previously reported congeners ( 6 – 8 ) were obtained from the whole plants of Ficus erecta . Their structures were determined by comprehensive analysis of 1D and 2D NMR and HRESIMS data. The identities and configurations of the monosaccharide units were established after hydrolysis and subsequent chiral derivatization followed by HPLC analysis. Notably, ficuserectoside E ( 5 ) was established as a Z ‐configured prenylated coumarin glucoside, enabling revision of a previously misassigned related structure. All of the isolates were evaluated in lipopolysaccharide (LPS)‐stimulated RAW264.7 macrophages and in a 6‐hydroxydopamine (6‐OHDA)‐induced PC12 cell injury model. None of the compounds significantly inhibited nitric oxide (NO) production at 25 or 50 µM. However, compounds 5 and 8 dose‐dependently (12.5–50 µM) improved PC12 cells survival, as evidenced by reduced intracellular reactive oxygen species (ROS) accumulation and increased cellular glutathione (GSH) levels. The present findings not only broaden the structural spectrum of Ficus erecta phenolic glycosides but also highlight selected glycosylated phenolics as promising leads for antioxidant‐based neuroprotective candidates.
- 10 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Open AccessPhenolic Glycosides From Ficus erecta and Their Anti‐Inflammatory and Neuroprotective Activities
Five undescribed phenolic glycosides, ficuserectosides A‐E ( 1 – 5 ), and three previously reported congeners ( 6 – 8 ) were obtained from the whole plants of Ficus erecta . Their structures were determined by comprehensive analysis of 1D and 2D NMR and HRESIMS data. The identities and configurations of the monosaccharide units were established after hydrolysis and subsequent chiral derivatization followed by HPLC analysis. Notably, ficuserectoside E ( 5 ) was established as a Z ‐configured prenylated coumarin glucoside, enabling revision of a previously misassigned related structure. All of the isolates were evaluated in lipopolysaccharide (LPS)‐stimulated RAW264.7 macrophages and in a 6‐hydroxydopamine (6‐OHDA)‐induced PC12 cell injury model. None of the compounds significantly inhibited nitric oxide (NO) production at 25 or 50 µM. However, compounds 5 and 8 dose‐dependently (12.5–50 µM) improved PC12 cells survival, as evidenced by reduced intracellular reactive oxygen species (ROS) accumulation and increased cellular glutathione (GSH) levels. The present findings not only broaden the structural spectrum of Ficus erecta phenolic glycosides but also highlight selected glycosylated phenolics as promising leads for antioxidant‐based neuroprotective candidates.
- 5 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71579
Six Undescribed Dibenzocyclooctadiene Lignans With Neuroprotective Effects From Kadsura coccinea Roots
Phytochemical investigation of the roots of Kadsura coccinea led to the isolation of eleven dibenzocyclooctadiene lignans ( 1–11 ), including six new compounds ( 1–6 ). Their structures were established by HRESIMS, NMR, and ECD analyses. All isolates were evaluated for neuroprotective effects against 6‐hydroxydopamine‐induced injury in PC12 cells. Compounds 2 and 10 showed the most potent activities, increasing cell viability by 20.54% and 30.67%, respectively, at 50 µM. Mechanistic studies indicated that both compounds reduced intracellular ROS accumulation and enhanced SOD activity, while compound 10 further activated the Nrf2/HO‐1 signaling pathway. These findings suggest that dibenzocyclooctadiene lignans from K. coccinea are promising neuroprotective agents against oxidative stress‐induced neuronal injury.
- 5 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71579
Six Undescribed Dibenzocyclooctadiene Lignans With Neuroprotective Effects From Kadsura coccinea Roots
Phytochemical investigation of the roots of Kadsura coccinea led to the isolation of eleven dibenzocyclooctadiene lignans ( 1–11 ), including six new compounds ( 1–6 ). Their structures were established by HRESIMS, NMR, and ECD analyses. All isolates were evaluated for neuroprotective effects against 6‐hydroxydopamine‐induced injury in PC12 cells. Compounds 2 and 10 showed the most potent activities, increasing cell viability by 20.54% and 30.67%, respectively, at 50 µM. Mechanistic studies indicated that both compounds reduced intracellular ROS accumulation and enhanced SOD activity, while compound 10 further activated the Nrf2/HO‐1 signaling pathway. These findings suggest that dibenzocyclooctadiene lignans from K. coccinea are promising neuroprotective agents against oxidative stress‐induced neuronal injury.